EPT Disclosure
May 24 2006 - 11:24AM
UK Regulatory
RNS Number:5350D
Deutsche Bank AG London
24 May 2006
FORM 38.5(a)
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS
WITH RECOGNISED INTERMEDIARY STATUS
DEALING IN A CLIENT-SERVING CAPACITY
(Rule 38.5(a) of the Takeover Code)
1. KEY INFORMATION
Name of exempt principal trader Deutsche Bank AG London
Company dealt in Cambridge Antibody Technology Group Plc
Class of relevant security to which the Ordinary
dealings being disclosed relate (Note 1)
Date of dealing 23/05/2006
2. DEALINGS (Note 2)
(a) Purchases and sales
Total number of securities purchased Highest price paid (Note 3) Lowest price paid (Note 3)
160,852 #13.08 #13.00
Total number of securities sold Highest price received (Note 3) Lowest price received (Note 3)
9,788 #13.055 #13.0365
(b) Derivatives transactions (other than options)
Product name, Long/short (Note 4) Number of securities (Note 5) Price per unit (Note 3)
e.g. CFD
CFD Long 4,000 #13.028907
CFD Long 127,200 #13.067162
(c) Options transactions in respect of existing securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, Number of securities Exercise Type, e.g. Expiry Option money
purchasing, to which the option American,
e.g. call option varying etc. relates (Note 5) price European etc. date paid/received per
unit (Note 3)
(ii) Exercising
Product name, e.g. call option Number of securities Exercise price per unit (Note 3)
3. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating
to the voting rights of any relevant securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is
referenced. If none, this should be stated.
Date of disclosure 24/05/2006
Contact name Kelly-Jade Ledwich
Telephone number 020 7545 7804
Name of offeree/offeror with which connected AstraZeneca Plc
Nature of connection (Note 6) Adviser to the offeror
Notes
The Notes on Form 38.5(a) can be viewed on the Takeover Panel's website at
www.thetakeoverpanel.org.uk
This information is provided by RNS
The company news service from the London Stock Exchange
END
EMMSEDFMLSMSEEI
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Jul 2024 to Aug 2024
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Aug 2023 to Aug 2024